Celltrion, Top Search Ranking... Stock Price -0.29%

As of 11:31 AM on the 8th, Celltrion is trading at 340,500 KRW, down 0.29% from the previous day. This represents an 11.33% decrease compared to January 12. Celltrion is known as a protein and biopharmaceutical manufacturing company.

Today, foreigners have net sold 13,274 shares of Celltrion, while institutions have net bought 12,000 shares, according to provisional data. Over the past five days, individual investors have net sold 741,021 shares, while foreigners and institutions have net bought 899,572 shares and net sold 75,608 shares, respectively.

On February 5, Celltrion became a market topic with the news of the approval decision for the 'first domestically produced COVID-19 treatment drug.'

[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.